RSV is a very common respiratory pathogen that can cause serious morbidity and mortality, tending to most adverselly affect the very young and the very old. RSV prophylaxis has had very limited availability until recent. There have been new additions to options for RSV prophylaxis for children and adults. This presentation will review RSV epidemiology and disease, as well as look at the new prophylaxis options.